Arena Pharmaceuticals Inc EV/EBIT

Was ist das EV/EBIT von Arena Pharmaceuticals Inc?

EV/EBIT von Arena Pharmaceuticals Inc ist N/A

Was ist die Definition von EV/EBIT?



Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.

ttm (trailing twelve months)

The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:

Enterprise value = market cap + total debt – cash and cash equivalents

The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.

EV/EBIT von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Arena Pharmaceuticals Inc

Was macht Arena Pharmaceuticals Inc?

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas

Unternehmen mit ev/ebit ähnlich Arena Pharmaceuticals Inc